Market overview
The global cartridge market is worth USD 1.7 bn in 2026 and is forecast to reach USD 3.4 bn by 2036, growing at a 7.2% CAGR. United States is the largest country market and Glass is the largest by material segment.
| Scope | Pre-filled and refillable cartridges for injectable drugs, insulin pens and dental anaesthetics, in glass and plastic with plungers and seals. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 1.6 bn |
| Value 2026 | USD 1.7 bn |
| Value 2036 | USD 3.4 bn |
| CAGR 2026-2036 | 7.2% |
| Volume 2026 | 4,045 million pieces |
| Volume 2036 | 7,338 million pieces |
| Average price 2026 | USD 0.43 per piece |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Cartridge market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 1.7 bn |
| 2027 | USD 1.8 bn |
| 2028 | USD 2.0 bn |
| 2029 | USD 2.1 bn |
| 2030 | USD 2.3 bn |
| 2031 | USD 2.4 bn |
| 2032 | USD 2.6 bn |
| 2033 | USD 2.8 bn |
| 2034 | USD 3.0 bn |
| 2035 | USD 3.2 bn |
| 2036 | USD 3.4 bn |
Cartridge market segmentation
By material
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Glass | 60.0% | 55.1% | USD 1.0 bn | 6.3% |
| Coated and treated glass | 18.0% | 18.2% | USD 310 mn | 7.3% |
| Plastic | 22.0% | 26.7% | USD 378 mn | 9.3% |
By end use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Insulin and diabetes | 36.0% | 31.8% | USD 619 mn | 5.9% |
| Dental anaesthesia | 20.0% | 15.3% | USD 344 mn | 4.4% |
| GLP-1 and other pen injectors | 24.0% | 33.5% | USD 413 mn | 10.8% |
| Biologics and others | 20.0% | 19.4% | USD 344 mn | 6.9% |
By filling type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pre-filled syringe cartridges | 46.0% | 50.0% | USD 791 mn | 8.1% |
| Dual chamber | 10.0% | 11.0% | USD 172 mn | 8.2% |
| Empty fillable | 44.0% | 39.0% | USD 757 mn | 5.9% |
By capacity
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Up to 1 ml | 34.0% | 32.0% | USD 585 mn | 6.5% |
| 1 to 3 ml | 46.0% | 46.0% | USD 791 mn | 7.2% |
| Above 3 ml | 20.0% | 22.0% | USD 344 mn | 8.2% |
By drug class
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Insulin and diabetes | 38.0% | 40.0% | USD 654 mn | 7.8% |
| Biologics | 26.0% | 30.0% | USD 447 mn | 8.8% |
| Vaccines | 14.0% | 12.0% | USD 241 mn | 5.6% |
| Others drugs | 22.0% | 18.0% | USD 378 mn | 5.1% |
Top 25 countries for cartridge by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 83.5% of 2026 revenue and the 25 countries below together hold 95.7%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 482 mn | 28.0% | USD 976 mn | 7.3% |
| 2 | China | USD 241 mn | 14.0% | USD 534 mn | 8.3% |
| 3 | Germany | USD 172 mn | 10.0% | USD 303 mn | 5.8% |
| 4 | India | USD 120 mn | 7.0% | USD 307 mn | 9.8% |
| 5 | Japan | USD 103 mn | 6.0% | USD 172 mn | 5.3% |
| 6 | France | USD 86 mn | 5.0% | USD 152 mn | 5.8% |
| 7 | United Kingdom | USD 69 mn | 4.0% | USD 128 mn | 6.4% |
| 8 | Denmark | USD 60 mn | 3.5% | USD 121 mn | 7.2% |
| 9 | Brazil | USD 52 mn | 3.0% | USD 110 mn | 7.9% |
| 10 | Italy | USD 52 mn | 3.0% | USD 90 mn | 5.7% |
| 11 | Switzerland | USD 44 mn | 2.6% | USD 84 mn | 6.6% |
| 12 | Netherlands | USD 34 mn | 1.9% | USD 64 mn | 6.6% |
| 13 | Mexico | USD 25 mn | 1.5% | USD 54 mn | 7.9% |
| 14 | Spain | USD 21 mn | 1.2% | USD 39 mn | 6.7% |
| 15 | Russia | USD 17 mn | 1.0% | USD 36 mn | 7.9% |
| 16 | Belgium | USD 14 mn | 0.8% | USD 27 mn | 6.7% |
| 17 | Poland | USD 11 mn | 0.7% | USD 24 mn | 8.0% |
| 18 | Australia | USD 9.3 mn | 0.5% | USD 18 mn | 6.8% |
| 19 | Canada | USD 7.7 mn | 0.5% | USD 14 mn | 6.5% |
| 20 | South Korea | USD 7.4 mn | 0.4% | USD 16 mn | 7.9% |
| 21 | Turkey | USD 6.5 mn | 0.4% | USD 14 mn | 8.0% |
| 22 | Thailand | USD 4.6 mn | 0.3% | USD 10 mn | 8.0% |
| 23 | Indonesia | USD 3.4 mn | 0.2% | USD 7.2 mn | 7.7% |
| 24 | Taiwan | USD 2.9 mn | 0.2% | USD 6.2 mn | 7.8% |
| 25 | Argentina | USD 2.4 mn | 0.1% | USD 4.8 mn | 7.2% |
| Rest of world | USD 74 mn | 4.3% | USD 136 mn | 6.3% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- SCHOTT
- Gerresheimer
- Stevanato Group
- Nipro
- BD
Group 2: Regional and specialist players
- SGD Pharma
- Bormioli Pharma
- Ypsomed
- West Pharmaceutical Services
- Datwyler
Group 3: Emerging and niche players
- Shandong Pharmaceutical Glass
- Chongqing Zhengchuan Pharmaceutical Packaging
- Neubor Glass
- Septodont
- Shandong Weigao Group
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the cartridge market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.2% is calculated from the resulting values.
The market is divided by material, by end use, by filling type, by capacity, by drug class. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the cartridge market?
The global cartridge market is estimated at USD 1.6 bn in 2025 and USD 1.7 bn in 2026.
How fast will the cartridge market grow?
It is forecast to reach USD 3.4 bn by 2036, a compound annual growth rate of 7.2% from 2026, an increase of USD 1.7 bn.
Which country is the largest market for cartridge?
United States is the largest market by revenue at USD 482 mn in 2026, 28.0% of the global total. The three largest countries together hold 52.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 9.8% a year from 2026 to 2036.
Which cartridge segment is largest?
In the by material split, Glass is the largest segment with 60.0% of 2026 revenue.
Who are the leading cartridge companies?
Global leaders include SCHOTT, Gerresheimer, Stevanato Group, Nipro.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- CentrifugeUSD 1.7 bn · 6.0% CAGR
- Digital Orthodontics Workflow SolutionsUSD 1.8 bn · 10.5% CAGR
- Mechanical Thrombectomy SystemUSD 1.7 bn · 10.0% CAGR
- Microplate ReaderUSD 1.7 bn · 6.5% CAGR
- Healthcare APIUSD 1.8 bn · 16.0% CAGR
- Animal Wound CareUSD 1.6 bn · 7.0% CAGR
- Rubber StopperUSD 1.6 bn · 6.3% CAGR
- NebulizerUSD 1.5 bn · 6.0% CAGR
← Carpal Tunnel Release System Catheter-Based Pulmonary Embolism Thrombectomy →